Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levetiracetam vs Magnesium Sulfate for Eclamptic Seizure Prevention
NCT07220902Phase 3Not yet recruiting
- Sponsor
- Methodist Health System
- Start
- Jan 2026
- Primary completion
- Dec 2033
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of levetiracetam in eclampsia, sponsored by Methodist Health System. Planned start Jan 2026; status: not yet recruiting.
02
Drugs
levetiracetam
03
Conditions
eclampsia
Beyond the preview
Go deeper on NCT07220902.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07220902.